Pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(l)(b) of SEBI (LODR) Regulations, 2015, Syncom Formulations (India) has informed regarding extract of Standalone Un-Audited Quarterly Financial Results for the Quarter ended 30th June, 2021 was approved in 02/2021-22 Meeting of Board of Directors held on Saturday, 14th August, 2021 at 2.00 pm at the Corporate Office of the company at 207, Saket Nagar, Indore (M.P) 452018. The company has enclosed the newspaper advertisement published on 15/08/2021 in Free Press Journal English edition and Marathi (vernacular) Newspaper.
The above information is a part of company’s filings submitted to BSE.
